Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.49 +0.08 (+18.98%)
At close: Oct 21, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Asset Utilization Ratio (2022)

Updated

Pasithea Therapeutics' (KTTA) Asset Utilization Ratio was 0.01 for Q4 2022.

Analysis

Pasithea Therapeutics (KTTA) Asset Utilization Ratio (2022) Analysis & Trends

  • By year, Asset Utilization Ratio came in at 0.00 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.62
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.49
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.47
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.52
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.46
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.51
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.58
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Pasithea Therapeutics 15.54 Mn -139.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 0.01
Sep 30, 2022 0.00
Jun 30, 2022 0.00
API Access

Pasithea Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=KTTA&period=max&api_key=YOUR_API_KEY